Video

Psychiatry Grand Rounds: “Life stories and engagement in underserved populations: Meeting mental health and SUD needs in the community”

Denis Antoine, M.D., FAPA, FASAM, applies the Life Story Perspective to re-think approaches to mental illness and substance use disorder treatments in order to improve individual and societal outcomes.

Video

Psychedelic Treatment with Psilocybin Relieves Major Depression

Roland Griffiths, director of Johns Hopkins Center for Consciousness and Psychedelic Research, describes a milestone study showing that psilocybin relieves major depression.

Video

Psychiatry Grand Rounds: “What is COVID Depression?”

Karen Swartz, M.D. highlights key findings from national surveys.

News

Adult Inpatient Brexanolone Service Addresses Postpartum Depression

A new service at Johns Hopkins offers a novel method to treat postpartum depression: administering a rapidly-acting intravenous medication in inpatient psychiatry units, where patients can benefit from related services.

News

Entrepreneurship Certificate Program Targets Prevention and Treatment of Substance Use Disorders

A $1.6M grant will fund efforts to train basic scientists in the development and commercialization of products to prevent and treat substance use disorders.

News

New Research into Treatment for Bipolar Depression

Johns Hopkins psychiatrists study whether an unconventional transcranial magnetic stimulation (TMS) yields more rapid improvements in patients.